Galactose peracetate is a derivative of galactose, a simple sugar. It is synthesized by reacting galactose with acetic anhydride in the presence of a catalyst. The resulting compound is a white, crystalline solid that is soluble in organic solvents but insoluble in water. Galactose peracetate has been studied for its potential applications in various fields, including as a building block for organic synthesis, as a potential drug delivery system, and as a component of biodegradable polymers. The molecule is also used to study enzyme activity and the mechanism of enzyme inhibition. Research into the compound explores its potential applications in pharmaceuticals, biomaterials, and materials science.'
galactose peracetate: RN given refers to 2,3,4,5,6-peracetate (D-Gal)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 81232 |
| SCHEMBL ID | 421756 |
| MeSH ID | M0087848 |
| Synonym |
|---|
| 6763-46-8 |
| d-galactose, 2,3,4,5,6-pentaacetate |
| galactose peracetate |
| AKOS015837931 |
| galactose pentaacetate |
| [(2r,3s,4s,5r)-2,3,4,5-tetraacetyloxy-6-oxohexyl] acetate |
| AKOS015920287 |
| SCHEMBL421756 |
| UAOKXEHOENRFMP-JJXSEGSLSA-N |
| [(2r,3s,4s,5r)-1,2,4,5-tetraacetyloxy-6-oxohexan-3-yl]acetate |
| DTXSID70884334 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.82) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||